Kedudukan dalam Saham
#36613
Arix Bioscience plc operates as a venture capital firm, focusing its... Arix Bioscience plc operates as a venture capital firm, focusing its investments across the entire lifecycle of companies, from nascent seed-stage ventures and preclinical or clinical asset development to early, mid, and late-stage growth capital rounds, encompassing both private and public equity. The firm's investment mandate is global, targeting the biotechnology sector and seeking out entities involved in groundbreaking therapeutics, cutting-edge technologies, and broader medical innovations spanning healthcare and life sciences. Employing an evergreen funding model, Arix Bioscience predominantly deploys capital directly from its own balance sheet. It generally prefers to secure a board position within its portfolio companies and strategically exits investments once the peak value has been realized. Established in 2015 and headquartered in London, United Kingdom, the company was previously known as Perceptive Bioscience Investments Limited.
Harga Saham
$1.93
Disegerakkan terakhir: 2024-02-09
Perubahan (1 tahun)
0.00%
Perdagangan Arix Bioscience plc (ARIX)
Harga ARIX dengan permodalan pasaran b
Modal pasaran bagi Arix Bioscience plc(ARIX)
Modal Pasaran: $2.50M
Sehingga August 2026, Arix Bioscience plc mempunyai modal pasaran sebanyak $2.50M. Ini menjadikan Arix Bioscience plc syarikat ke-36613th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Arix Bioscience plc dari 2017 hingga 2026
ARIX berbanding dengan 5 teratas yang paling popular stocks
| Harga ARIX |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.452T
|
+218,060,416.09%
|
|
|
|
|
$4.490T
|
+179,589,017.57%
|
|
|
|
|
$4.162T
|
+166,485,344.45%
|
|
|
|
|
$3.676T
|
+147,044,026.68%
|
|
|
|
|
$2.833T
|
+113,314,229.56%
|
